Factors influencing uptake of familial long QT syndrome genetic testing

American Journal of Medical Genetics, Part A

Volumn 170, Issue 2, 2016, Pages 418-425

  Burns, Charlotte ^a,b,c   Mcgaughran, Julie ^d,e   Davis, Andrew ^f,g,h   Semsarian, Christopher ^a,b,c   Ingles, Jodie ^a,b,c  

^a CENTENARY INSTITUTE   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^d ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^e UNIVERSITY OF QUEENSLAND   (Australia)

^f ROYAL CHILDREN'S HOSPITAL   (Australia)

^g MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^h UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Communication; Genetic testing; Long QT syndrome; Psychosocial; Uptake

Indexed keywords

ADULT; AGE; ANXIETY; ARTICLE; ASYMPTOMATIC DISEASE; CLINICAL ASSESSMENT; DEMOGRAPHY; DEPRESSION; FAMILIAL DISEASE; FEMALE; FIRST DEGREE RELATIVE; GENE MUTATION; GENETIC RISK; GENETIC SCREENING; HEALTH CARE ACCESS; HEALTH CARE UTILIZATION; HIGH RISK POPULATION; HUMAN; INTERPERSONAL COMMUNICATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QT PROLONGATION; SOCIAL STATUS; COMMUNICATION DISORDER; ELECTROCARDIOGRAPHY; FAMILY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; LONG QT SYNDROME; MIDDLE AGED; PHENOTYPE; PSYCHOLOGY; RETROSPECTIVE STUDY; SOCIOECONOMICS; UTILIZATION;

ADULT; COMMUNICATION BARRIERS; ELECTROCARDIOGRAPHY; FAMILY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GENOTYPE; HUMANS; LONG QT SYNDROME; MALE; MIDDLE AGED; PHENOTYPE; RETROSPECTIVE STUDIES; SOCIOECONOMIC FACTORS;

EID: 84956886797     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.37455     Document Type: Article

References (44)

1. Ackerman MJ, Priori SG, Willems S, Berul C, Brugada R, Calkins H, Camm AJ, Ellinor PT, Gollob M, Hamilton R, Hershberger RE, Judge DP, Le Marec H, McKenna WJ, Schulze-Bahr E, Semsarian C, Towbin JA, Watkins H, Wilde A, Wolpert C, Zipes DP. 2011. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies. Heart Rhythm 8:1308-1339.
2. Aktan-Collan K, Mecklin JP, Jarvinen H, Nystrom-Lahti M, Peltomaki P, Soderling I, Uutela A, de la Chapelle A, Kaariainen H. 2000. Predictive genetic testing for hereditary non-polyposis colorectal cancer: Uptake and long-term satisfaction. Int J Cancer 89:44-50.
3. Australian Bureau of Statistics. 2008. Information Paper: An introduction to socio-economic indexes for areas (SEIFA). Canberra.
4. Barsevick AM, Montgomery SV, Ruth K, Ross EA, Egleston BL, Bingler R, Malick J, Miller SM, Cescon TP, Daly MB. 2008. Intention to communicate BRCA1/BRCA2 genetic test results to the family. J Fam Psychol 22:303-312.
5. Boyes AW, Girgis A, Zucca AC, Lecathelinais C. 2009. Anxiety and depression among long-term survivors of cancer in Australia: Results of a population-based survey. Med J Aust 190:S94-S98.
6. Brooks L, Lennard F, Shenton A, Lalloo F, Ambus I, Ardern-Jones A, Belk R, Kerr B, Craufurd D, Eeles R, Gareth Evans D. 2004. BRCA1/2 predictive testing: A study of uptake in two centres. Eur J Hum Genet 12:654-662.
7. Buhr K, Dugas MJ. 2002. The intolerance of uncertainty scale: Psychometric properties of the English version. Behav Res Ther 40:931-945.
8. Butel-Simoes GI, Spigelman AD. 2014. Analysis of patient reports on the referral process to two NSW cancer genetic services. Fam Cancer 13:333-343.
9. Christiaans I, van Langen M, Birnie E, Bonsel G, Wilde A, Smets E. 2009. Genetic counseling and cardiac care in predictively tested hypertrophic cardiomyopathy mutation carriers: The patients' perspective. Am J Med Genet Part A 149A:1444-1451.
10. Christiaans I, Birnie E, Bonsel GJ, Wilde AA, van Langen IM. 2008a. Uptake of genetic counselling and predictive DNA testing in hypertrophic cardiomyopathy. Eur J Hum Genet 16:1201-1207.
11. Christiaans I, Birnie E, Bonsel GJ, Wilde AAM, van Langen IM. 2008b. Uptake of genetic counselling and predictive DNA testing in hypertrophic cardiomyopathy. Eur J Hum Genet 16:1201-1207.
12. Cox S, O'Donoghue AC, McKenna WJ, Steptoe A. 1997. Health related quality of life and psychological wellbeing in patients with hypertrophic cardiomyopathy. Heart 78:182-187.
13. Crawford JR, Henry JD, Crombie C, Taylor EP. 2001. Normative data for the HADS from a large non-clinical sample. Br J Clin Psychol 40:429-434.
14. Earle N, Crawford J, Smith W, Hayes I, Shelling A, Hood M, Stiles M, Maxwell F, Heaven D, Love DR, Skinner JR. 2013. Community detection of long QT syndrome with a clinical registry: An alternative to ECG screening programs? Heart Rhythm 10:233-238.
15. Finlay E, Stopfer JE, Burlingame E, Evans KG, Nathanson KL, Weber BL, Armstrong K, Rebbeck TR, Domchek SM. 2008. Factors determining dissemination of results and uptake of genetic testing in families with known BRCA1/2 mutations. Genet Test 12:81-91.
16. Forrest LE, Curnow L, Delatycki MB, Skene L, Aitken M. 2008. Health first, genetics second: Exploring families' experiences of communicating genetic information. Eur J Hum Genet 16:1329-1335.
17. Goldenberg I, Horr S, Moss AJ, Lopes CM, Barsheshet A, McNitt S, Zareba W, Andrews ML, Robinson JL, Locati EH, Ackerman MJ, Benhorin J, Kaufman ES, Napolitano C, Platonov PG, Priori SG, Qi M, Schwartz PJ, Shimizu W, Towbin JA, Vincent GM, Wilde AA, Zhang L. 2011. Risk for life-threatening cardiac events in patients with genotype-confirmed long-QT syndrome and normal-range corrected QT intervals. J Am Coll Cardiol 57:51-59.
18. Hamang A, Eide GE, Nordin K, Rokne B, Bjorvatn C, Oyen N. 2010. Health status in patients at risk of inherited arrhythmias and sudden unexpected death compared to the general population. BMC Med Genet 11:27.
19. Hendriks KS, Grosfeld FJ, Wilde AA, van den Bout J, van Langen IM, van Tintelen JP, ten Kroode HF. 2005. High distress in parents whose children undergo predictive testing for long QT syndrome. Community Genet 8:103-113.
20. Hendriks KS, Hendriks MM, Birnie E, Grosfeld FJ, Wilde AA, van den Bout J, Smets EM, van Tintelen JP, ten Kroode HF, van Langen IM. 2008. Familial disease with a risk of sudden death: A longitudinal study of the psychological consequences of predictive testing for long QT syndrome. Heart Rhythm 5:719-724.
21. Hofman N, Tan H, Alders M, van Langen I, Wilde A. 2010. Active cascade screening in primary inherited arrhythmia syndromes. J Am Coll Cardiol 55:2570-2576.
22. Ingles J, Johnson R, Sarina T, Yeates L, Burns C, Gray B, Ball K, Semsarian C. 2015. Social determinants of health in the setting of hypertrophic cardiomyopathy. Int J Cardiol 184:743-749.
23. Ingles J, Lind JM, Phongsavan P, Semsarian C. 2008a. Psychosocial impact of specialized cardiac genetic clinics for hypertrophic cardiomyopathy. Genet Med 10:117-120.
24. Ingles J, McGaughran J, Vohra J, Weintraub R, Davis A, Atherton J, Semsarian C. 2008b. Establishment of an australian national genetic heart disease registry. Heart Lung Circ 17:463-467.
25. Ingles J, Semsarian C. 2013. The Australian genetic heart disease registry. Int J Cardiol 168:127-128.
26. Ingles J, Sarina T, Kasparian N, Semsarian C. 2013a. Psychological wellbeing and postraimatic stress associated with implantable cardioverter defibrillator therapy in young adults with genetic heart disease. Int J Cardiol 168:3779-3784.
27. Ingles J, Yeates L, Hunt L, McGaughran J, Scuffham PA, Atherton J, Semsarian C. 2013b. Health status of cardiac genetic disease patients and their at-risk relatives. Int J Cardiol 165:448-453.
28. Kodl MM, Lee JW, Matthews AK, Cummings SA, Olopade OI. 2006. Correlates of depressive symptoms among women seeking cancer genetic counseling and risk assessment at a high-risk cancer clinic. J Genet Couns 15:267-276.
29. Korda RJ, Banks E, Clements MS, Young AF. 2009. Is inequity undermining Australia's 'universal' health care system? Socio-economic inequalities in the use of specialist medical and non-medical ambulatory health care. Aust N Z J Public Health 33:458-465.
30. Korda RJ, Butler JR, Clements MS, Kunitz SJ. 2007. Differential impacts of health care in Australia: Tend analysis of socioeconomic inequalities in avoidable mortality. Int J Epidemiol 36:157-165.
31. MacCormick JM, McAlister H, Crawford J, French JK, Crozier I, Shelling AN, Eddy CA, Rees MI, Skinner JR. 2009. Misdiagnosis of long QT syndrome as epilepsy at first presentation. Ann Emerg Med 54:26-32.
32. Miller EM, Wang Y, Ware SM. 2013. Uptake of cardiac screening and genetic testing among hypertrophic and dilated cardiomyopathy families. J Genet Couns 22:258-267.
33. Montgomery SV, Barsevick AM, Egleston BL, Bingler R, Ruth K, Miller SM, Malick J, Cescon TP, Daly MB. 2013. Preparing individuals to communicate genetic test results to their relatives: Report of a randomized control trial. Fam Cancer 12:537-546.
34. O'Neill SC, DeMarco T, Peshkin BN, Rogers S, Rispoli J, Brown K, Valdimarsdottir H, Schwartz MD. 2006. Tolerance for uncertainty and perceived risk among women receiving uninformative BRCA1/2 test results. Am J Med Genet Part C 142C:251-259.
35. Ormondroyd E, Oates S, Parker M, Blair E, Watkins H. 2014. Pre-symptomatic genetic testing for inherited cardiac conditions: A qualitative exploration of psychosocial and ethical implications. Eur J Hum Genet 22:88-93.
36. Patenaude AF, Dorval M, DiGianni LS, Schneider KA, Chittenden A, Garber JE. 2006. Sharing BRCA1/2 test results with first-degree relatives: Factors predicting who women tell. J Clin Oncol 24:700-706.
37. Peterson SK, Watts BG, Koehly LM, Vernon SW, Baile WF, Kohlmann WK, Gritz ER. 2003. How families communicate about HNPCC genetic testing: Findings from a qualitative study. Am J Med Genet Part C 119C:78-86.
38. Priori SG, Napolitano C, Schwartz PJ. 1999. Low penetrance in the long-QT syndrome: Clinical impact. Circulation 99:529-533.
39. Priori SG, Napolitano C, Schwartz PJ, Grillo M, Bloise R, Ronchetti E, Moncalvo C, Tulipani C, Veia A, Bottelli G, Nastoli J. 2004. Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers. J Am Med Assoc 292:1341-1344.
40. Priori SG, Wilde AA, Horie M, Cho Y, Behr ER, Berul C, Blom N, Brugada J, Chiang CE, Huikuri H, Kannankeril P, Krahn A, Leenhardt A, Moss A, Schwartz PJ, Shimizu W, Tomaselli G, Tracy C. 2013. HRS/EHRA/APHRS Expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes. Heart Rhythm 10:1932-1963.
41. Teng I, Spigelman A. 2014. Attitudes and knowledge of medical practitioners to hereditary cancer clinics and cancer genetic testing. Fam Cancer 13:311-324.
42. Theilade J, Kanters J, Henriksen FL, Gilsa-Hansen M, Svendsen JH, Eschen O, Toft E, Reimers JI, Tybjaerg-Hansen A, Christiansen M, Jensen HK, Bundgaard H. 2013. Cascade screening in families with inherited cardiac diseases driven by cardiologists: Feasibility and nationwide outcome in long QT syndrome. Cardiology 126:131-137.
43. van der Roest WP, Pennings JM, Bakker M, van den Berg MP, van Tintelen JP. 2009. Family letters are an effective way to inform relatives about inherited cardiac disease. Am J Med Genet Part A 149A:357-363.
44. van Langen IM, Birnie E, Leschot NJ, Bonsel GJ, Wilde AA. 2003. Genetic knowledge and counselling skills of Dutch cardiologists: Sufficient for the genomics era? Eur Heart J 24:560-566.